DuPont de Nemours

Q2 FY2026 EarningsQ2 FY26 results beat consensus across all key metrics: adjusted EPS of $1.88 exceeded the $1.76 mean estimate (+6.8%), while revenue of $1.82B slightly outperformed the $1.81B expected. Growth was driven by 4% organic sales expansion, particularly in Healthcare & Water Technologies. Consequently, management raised FY26 adjusted EPS guidance to $7.24, well above the previous consensus, supported by robust AI-related water demand and aerospace strength.